Ferrous bisglycinate is an investigational drug.
There have been 3 clinical trials for Ferrous bisglycinate.
The most recent clinical trial was a Phase 3 trial, which was initiated on February 1st 2017.
The most common disease conditions in clinical trials are Anemia, Anemia, Iron-Deficiency, and Deficiency Diseases. The leading clinical trial sponsors are GlaxoSmithKline, Assiut University, and Hatem AbuHashim.